NVIV stock forecast
Our latest prediction for Invivo Therapeutics Holdings Corp.'s stock price was made on the March 10, 2020 when the stock price was at 1.79$.
In the short term (2weeks), NVIV's stock price should outperform the market by 6.62%. During that period the price should oscillate between -14.49% and +33.49%.
In the medium term (3months), NVIV's stock price should outperform the market by 2.98%. During that period the price should oscillate between -46.19% and +82.31%.Get email alerts
Create a solid portfolio with NVIV
About Invivo Therapeutics Holdings Corp.
Invivo Therapeutics Holdings Corp. operates as a research and clinical-stage biotechnology company, which engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries. Its clinical development program is the Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord. The company was founded by Joseph P. Vacanti, Frank M. Reynolds, and Robert Langer in January 2005 and is headquartered in Cambridge, MA.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -35.28$ per share.
The book value per share is -0.25$
Three months stock forecastMarch 10, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|